These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22260818)

  • 1. Effect of oral clodronate on structural damage and bone turnover in rheumatoid arthritis.
    Valleala H; Laasonen L; Koivula MK; Risteli J; Konttinen YT
    Clin Exp Rheumatol; 2012; 30(1):114-7. PubMed ID: 22260818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease.
    Valleala H; Laasonen L; Koivula MK; Mandelin J; Friman C; Risteli J; Konttinen YT
    J Rheumatol; 2003 Mar; 30(3):468-73. PubMed ID: 12610803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
    Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
    J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy.
    Barnabe C; Hanley DA
    Semin Arthritis Rheum; 2009 Oct; 39(2):116-22. PubMed ID: 18585759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral clodronate on bone mass, bone turnover and subsequent metastases in women with primary breast cancer.
    McCloskey E; Paterson A; Kanis J; Tähtelä R; Powles T
    Eur J Cancer; 2010 Feb; 46(3):558-65. PubMed ID: 20031392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study.
    Engvall IL; Svensson B; Tengstrand B; Brismar K; Hafström I;
    Arthritis Res Ther; 2008; 10(6):R128. PubMed ID: 18986531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical response to single infusion of clodronate in active rheumatoid arthritis--a double blind placebo controlled study.
    Valleala H; Laitinen K; Pylkkänen L; Konttinen YT; Friman C
    Inflamm Res; 2001 Dec; 50(12):598-601. PubMed ID: 11822785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis.
    Ebina K; Hirao M; Hashimoto J; Matsuoka H; Iwahashi T; Chijimatsu R; Etani Y; Okamura G; Miyama A; Yoshikawa H
    Osteoporos Int; 2018 Jul; 29(7):1627-1636. PubMed ID: 29574517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of bone markers in a 6-week study to assess the efficacy of oral clodronate in patients with metastatic bone disease.
    Brown JE; McCloskey EV; Dewar JA; Body JJ; Cameron DA; Harnett AN; Ruutu M; Purohit OP; Tähtelä R; Coleman RE
    Calcif Tissue Int; 2007 Nov; 81(5):341-51. PubMed ID: 17874331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial.
    Richbourg HA; Mitchell CF; Gillett AN; McNulty MA
    BMC Vet Res; 2018 Mar; 14(1):105. PubMed ID: 29554967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study.
    Hafström I; Albertsson K; Boonen A; van der Heijde D; Landewé R; Svensson B;
    Ann Rheum Dis; 2009 Apr; 68(4):508-13. PubMed ID: 18420939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
    Tuppurainen M; Härmä K; Komulainen M; Kiviniemi V; Kröger H; Honkanen R; Alhava E; Jurvelin J; Saarikoski S
    Maturitas; 2010 Aug; 66(4):423-30. PubMed ID: 20547017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of TNF α antagonist therapy on bone metabolism in rheumatoid arthritis: a systematic review.
    Sakthiswary R; Das S
    Curr Drug Targets; 2013 Dec; 14(13):1552-7. PubMed ID: 23848441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis.
    Daubiné F; Le Gall C; Gasser J; Green J; Clézardin P
    J Natl Cancer Inst; 2007 Feb; 99(4):322-30. PubMed ID: 17312309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
    Jensen TW; Hansen MS; Hørslev-Petersen K; Hyldstrup L; Abrahamsen B; Langdahl B; Zerahn B; Pødenphant J; Stengaard-Petersen K; Junker P; Østergaard M; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Lindegaard H; Jurik AG; Vestergaard A; Hetland ML;
    Ann Rheum Dis; 2014 Jun; 73(6):1123-9. PubMed ID: 23661492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.
    Torikai E; Kageyama Y; Takahashi M; Nagano A
    Mod Rheumatol; 2006; 16(6):350-4. PubMed ID: 17164995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction.
    Skoumal M; Haberhauer G; Kolarz G; Hawa G; Woloszczuk W; Klingler A
    Arthritis Res Ther; 2005; 7(1):R65-70. PubMed ID: 15642144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striking difference of periarticular bone density change in early psoriatic arthritis and rheumatoid arthritis following anti-rheumatic treatment as measured by digital X-ray radiogrammetry.
    Szentpetery A; Heffernan E; Haroon M; Kilbane M; Gallagher P; McKenna MJ; FitzGerald O
    Rheumatology (Oxford); 2016 May; 55(5):891-6. PubMed ID: 26850991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
    Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P
    Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.